← All indications
Anxiety Disorders
Persistent and disabling ANXIETY.
Subtype terms (7)
More specific conditions that are subtypes of Anxiety Disorders in the MeSH hierarchy.
- Anxiety, Separation
11 drugs approved
- Generalized Anxiety Disorder
- Neurocirculatory Asthenia
1 drug experimental
- Neurotic Disorders
3 drugs approved
- Obsessive-Compulsive Disorder
68 drugs (56 approved, 12 experimental)
- Panic Disorder
42 drugs (34 approved, 8 experimental)
- Phobic Disorders
9 drugs (7 approved, 2 experimental)
Drugs by status
Approved for this indication (18)
Phase 4 trials (43)
- nitrous oxide
- mifepristone
- acamprosate
- amitriptyline
- oxytocin
- black cohosh
- bryophyllum
- butorphanol
- chamomile
- ketamine
- citalopram
- methylphenidate
- disulfiram
- valproic acid
- fluvoxamine
- ziprasidone
- sertraline
- esketamine
- kava
- fluoxetine
- naproxen
- nefazodone
- olanzapine
- propranolol
- remimazolam
- rhodiola
- risperidone
- rotigotine
- buprenorphine
- desvenlafaxine
- +13 more
Phase 3 trials (101)
- flupentixol
- melatonin
- phenobarbital
- piracetam
- methylprednisolone
- lysergic acid diethylamide
- agomelatine
- amibegron
- aqw051
- biperiden
- bromperidol
- lamotrigine
- chlorprothixene
- clobazam
- emineurina
- clonazepam
- clozapine
- diphenhydramine
- centanafadine
- cannabidiol
- galantamine
- fluphenazine
- fluspirilene
- gabapentin
- zopiclone
- haloperidol
- hypericum perforatum
- icosapent ethyl
- imipramine
- carbamazepine
- +71 more
Phase 2 trials (37)
- azd-7325
- cariprazine
- cerc-501
- echinacea
- emapunil
- gemcitabine
- l-glutamine
- guanfacine
- sodium oxybate
- mk-0777
- myoinositol
- neuropeptide Y
- pf-06372865
- 3,4-Methylenedioxymethamphetamine
- rufinamide
- cellulose
- vestipitant
- ashwagandha extract
- btrx-246040
- lactobacillus plantarum
- multivitamins
- cisplatin
- nelivaptan
- psilocybin
- dextromethorphan
- pramipexole
- baclofen
- galphimia glauca
- curcumae radix
- chen pi
- +7 more
Phase 1 trials (18)
Other trials (27)
- urea
- cetearyl alcohol
- lavender
- mulberry leaf extract
- thiopental
- bifidobacterium longum
- human fecal microbiota
- almond
- lactobacillus helveticus
- fentanyl
- bupleurum
- eschscholtzia
- peppermint extract
- sodium chloride
- minocycline
- desipramine
- prilocaine
- isoprenaline
- remifentanil
- exosomes from mesenchymal stem cells
- lactobacillus casei
- rutin
- ampelosin
- lactobacillus reuteri
- hypothalamic phospholipids
- oyster shell decoction
- leonurus cardiaca extract
Organizations
Organization Involved with Phase 4 Indications (112)
- Cephalon
- Shire
- Sumitomo
- Bristol-Myers Squibb
- AstraZeneca
- Pfizer
- Purdue Pharmaceuticals
- Wyeth
- Hamilton Health Sciences Corporation
- Hugo W. Moser Research Institute at Kennedy Krieger, Inc.
- Lallemand SAS
- Materia Medica Holding
- Sunovion
- Dr Alexander McIntyre Inc.
- National Institutes of Health (NIH)
- National Center for Complementary and Integrative Health (NCCIH)
- National Institute of Mental Health (NIMH)
- National Institute on Aging (NIA)
- National Institute on Alcohol Abuse and Alcoholism (NIAAA)
- United States Army
- Lehigh Valley Hospital
- Huazhong University of Science and Technology
- Aarhus University
- University of Pennsylvania
- Acadia University
- University of Pittsburgh
- Boston University
- Chang Gung University
- University of London
- Cornell University
- +82 more
Organization Involved with Phase 3 Indications (40)
- Actavis
- Epix Pharmaceuticals
- Jazz Pharmaceuticals
- Takeda
- Sanofi
- Allergan
- Ativus Farmaceutica Ltda
- Corporation de Recherche en Neuropsycho Pharmacologie de Quebec
- Edgemont Pharmaceuticals, LLC
- Marjan Industria e Comercio ltda
- Pherin Pharmaceuticals, Inc.
- Tilray
- Boehringer Ingelheim
- Otsuka
- National Center of Neurology and Psychiatry, Japan
- National Nutrition and Food Technology Institute
- Millet Roux
- University Hospitals Cleveland Medical Center
- Brown University
- Case Western Reserve University
- Cedars-Sinai Medical Center
- Faculdade de Medicina do ABC
- Temple University
- Gottfried Wilhelm Leibniz Universität Hannover
- Loma Linda University
- Mashhad University of Medical Sciences
- Ohio State University
- Rhode Island Hospital
- University of Hull
- University of Tehran
- +10 more
Organization Involved with Phase 2 Indications (41)
- Merck
- Novartis
- Avera Pharmaceuticals
- Biotie Therapies
- BrainCells Inc.
- EuroPharma, Inc.
- INC Research
- Natreon, Inc.
- National Cancer Institute (NCI)
- National Institute of Neurological Disorders and Stroke (NINDS)
- National Institute on Drug Abuse (NIDA)
- Baylor University
- CES University
- Georgia State University
- Indiana University
- Los Angeles Biomedical Research Institute
- Medical University of Bialystok
- Multidisciplinary Association for Psychedelic Studies
- Universidad Autonoma de Nuevo Leon
- Universidade Federal de Sergipe
- University of Bern
- Zagazig University
- Mayo Clinic
- Tel Aviv University
- University of British Columbia
- University of California, Davis
- Department of Defense
- University of Campinas
- Government of Mexico
- Federal University of Sergipe
- +11 more
Organization Involved with Phase 1 Indications (19)
- Azevan Pharmaceuticals
- NuBiyota
- University of Manitoba
- Anhui Medical University
- Harbin Medical University
- Nanjing Medical University
- University of Houston
- University of Florida
- University of Ottawa
- Capital Medical University
- Wenzhou Medical University
- Tianjin Medical University
- Sao Paulo State University
- Heffter Research Institute
- Patterson Trust Awards Program in Clinical Research
- University of Electronic Science and Technology of China
- the First Specialized Subject Hospital of Harbin
- Beijing Winsunny Pharmceutical Co.,Ltd.
- Wuhan Psychiatric Hospital
Organization Involved with Other Experimental Indications (39)
- Unilever
- Veterans Medical Research Foundation
- United States Air Force
- United States Navy
- First Teaching Hospital of Tianjin University of Traditional Chinese Medicine
- University of Arizona
- Central South University
- Hôpital d'enfants Béchir-Hamza
- Inje University
- National University of Malaysia
- Neurological Associates of West Los Angeles
- Northwestern University
- St. John's Research Institute
- Universidad Nacional de Rosario
- University of Rochester
- Valley Anesthesiology Consultants
- Taipei Medical University
- Tianjin University of Traditional Chinese Medicine
- University of California, San Francisco
- University of Basel
- Laureate Institute for Brain Research
- National Taiwan University
- CHU AMBROISE PARE
- University of Montreal
- Pennsylvania State University
- University of Texas, Galveston
- MRA Clinical Research
- University of Genoa
- University of Quebec
- The Defense and Veterans Brain Injury Center
- +9 more